Based on a secure open-source platform developed by researchers at the Luxembourg Institute of Science and Technology (LIST) in partnership with the Luxembourgish doctors, GECAMed® enables the management and use of medical data. First launched in 2005, the software has been continuously adapted and improved to meet the needs of healthcare professionals. Moreover, numerous Luxembourgish businesses and institutions have contributed to it, including the eSanté agency, the Luxembourgish Association of Doctors and Dentists (AMMD), the Robert Schuman hospitals, Doctena, Agfa Healthcare, Astrazeneca and Pfizer, making GECAMed® a tool specifically adapted to the specific Luxembourgish context. The developments begun in this last decade have paid off since GECAMed® is used by almost 10% of Luxembourgish doctors as well as by all medical centres (maisons médicales) in Luxembourg.


GECAMed® was no longer the object of any true innovations after reaching technological maturity and being integrated into the eSanté platform in November 2015. With this step, researchers achieved their final development objectives by providing healthcare professionals with a tool capable of using the shared patient records (DSP) in a user-friendly and transparent way.

From this point on, LIST’s role was focused mainly on software maintenance. After recognizing that maintaining and continuing to develop software in a competitive market is not the vocation of a research and technology organization like LIST, it was a natural decision to transfer GECAMed® to a service provider.


Although well established in the Luxembourgish business landscape, GECAMed® nevertheless faces significant challenges of guaranteeing its continuity and development to remain close to the needs of Luxembourgish healthcare professionals. LIST wanted to develop a strong partnership capable of efficiently managing the relationship with existing users, future marketing and functional and technical development of the software. Therefore LIST launched a public offering to find a trusted partner to undertake the GECAMed® developments. LIST finally put its trust in ABACUS Consulting & Solutions S.A., an innovative Luxembourgish service provider specialized in Business-IT alignment and IT business solutions. As official support provider of GECAMed® since 2016, ABACUS was a natural choice of candidate for its takeover.

The agreement signed between the two parties confirms the open-source character of GECAMed®, whose source codes and standardized import and export formats for patient files remain public. Finally, future GECAMed® developments will be carried out according to the add-on principle, making it possible to add new functionalities identified together with users.

In order to make the software transfer to the company as smooth as possible, LIST researchers trained ABACUS employees in the specificities of their software. ABACUS now has detailed knowledge in terms of GECAMed® functionality and its technical architecture.


The takeover of the software by ABACUS is a chance for GECAMed® to remain at the cutting edge of the needs and requests of the market. Upcoming developments and future functionalities will also support Luxembourgish doctors in terms of the new Luxembourgish legislative obligations they will face in 2018, in particular, the obligation to use a double-entry bookkeeping method.

Since January 1st 2018, ABACUS proposes a version of GECAMed® adapted to the needs of professional users. This version comprises not only extended functionalities but also the associated support. It will be complemented in the future by a range of professional services specially adapted to the needs of doctors and tailored to the specific requirements of medical practices: IT consulting in terms of data protection, IT materials and equipment for practices, adapted training and installation and configuration of the software. ABACUS thus provides Luxembourgish doctors with an all-in-one offer for their practices’ IT requirements based around GECAMed®. In addition, ABACUS also proposes customized development for doctors’ and practices’ in order to cover their individual needs.

An open-source version of GECAMed will continue to be available, with a focus on research, education and non-profit purposes. This version will however not have the complete range of functionalities offered in the professional version.

Photo: © LIST

Read more

“An international view on the European healthtech market”


Carole Brückler at the Luxembourg Ministry of the Economy speaks about why companies should attend the European Digital Healthtech Conference on 14-15 May 2024.
Read more

56 days until the 2024 European Digital HealthTech Conference


Register for a unique conference exploring the challenges of bringing health technologies to the market and their solutions from 14 to 15 May 2024 in Luxembourg. A call for speakers is also open until 16 April.
Read more

New webinars for healthtech companies


The Luxembourg HealthTech Cluster, managed by Luxinnovation, is paving the way for healthtech companies to navigate the complexities of launching their products on the European market through a series of webinars. The objective: to equip companies with insights that will facilitate their entry into the European market.
Read more

Applying for EIC Accelerator funding: How to succeed


The EIC Accelerator is one of the most prestigious and attractive, but also one of the most competitive, funding instruments of Horizon Europe for individual start-ups and small companies developing and scaling up game-changing innovations. Three former Fit 4 Start participants who have received funding shared their best advice about do’s and don’ts at the Fit 4 Start Alumni event held on 25 May 2023.
Read more

Digital health solutions: enabling market launch for “European champions”


There’s been progress on digital medical device regulations, but what existing barriers hinder the uptake of innovations on the European market. And what solutions are available? This was the focus of the European Digital Healthtech Hub Conference in Luxembourg, which emphasised the importance of harmonised standards and private investor engagement, best practices and other actions that can be taken.
Read more

All news